Lung Cancer and Posttraumatic Stress Symptoms: Predictive Factors and Subgroup Analysis

10.4103/TPSY.TPSY_32_22

Pei-Lun Chung；Shu-I Wu；Hong-Ming Chen；Vincent Chin-Hung Chen；Min-Jing Lee

depressive symptoms ； chemotherapy ； surgery ； education level

台灣精神醫學

36卷4期（2022 / 12 / 01）

157 - 163

英文

Objective: Lung cancer is the most common cancer and the leading cause of cancer death worldwide. Research on the correlation between posttraumatic stress symptoms (PTSSs) and lung cancer is limited. In this study, we intended to study PTSS predictors in patients with lung cancer and their subgroups. Methods: Patients aged ≥ 20 years with lung cancer diagnosis were recruited. We collected information on demographic characteristics, depressive symptoms, and cognitive function, to examine the effect on PTSSs. With the Chinese version of the startle, physiological arousal, anger, and numbness questionnaire, we analyzed the variables to identify the independent correlates of PTSSs and to compare differences among treatment and cancer stage subgroups. Results: A total of 329 lung cancer patients were included with prominent male, below senior high school education level, married status, unemployment, smoking history, non-alcohol drinker, without psychiatric history and comorbid diabetes and hypertension. The correlates of PTSSs were significantly higher in education level (β = 0.197, p ＜ 0.01), cognitive function (β = -0.269, p ＜ 0.001), and depressive symptoms (β = 0.294, p ＜ 0.001). In subgroup analysis, high education level was significantly correlated of PTSSs in different treatment groups surgery group (β = 0.266, p ＜ 0.05), nonsurgery group (β = 0.204, p ＜ 0.05), chemotherapy group (β = 0.189, p ＜ 0.05), and nonchemotherapy group (β = 0.220, p ＜ 0.05). Cognitive function was significantly correlated of PTSSs in different cancer stages in early stage (β = -0.401, p ＜ 0.01) and advanced stage (β = -0.182, p ＜ 0.05). Conclusion: Depressive symptoms, high education level, and the poor cognitive function were significantly associated with PTSSs in patients with lung cancer. Health professionals in oncology should consider psychological burden screening, cognitive function examination, and rehabilitation in clinical practice.

1. Abbey, G,Thompson, SB,Hickish, T(2015).A meta-analysis of prevalence rates and moderating factors for cancer-related post-traumatic stress disorder.Psychooncology,24,371-381.
2. Akechi, T,Okamura, H,Nishiwaki, Y(2001).Psychiatric disorders and associated and predictive factors in patients with unresectable nonsmall cell lung carcinoma: A longitudinal study.Cancer,92,2609-2622.
3. Alter, CL,Pelcovitz, D,Axelrod, A(1996).Identification of PTSD in cancer survivors.Psychosomatics,37,137-143.
4. Bryant, RA,Harvey, AG(1995).Psychological impairment following motor vehicle accidents.Aust J Public Health,19,185-188.
5. Carlsson, AM(1983).Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale.Pain,16,87-101.
6. Chen, CH,Shen, WW,Tan, HK(2003).The validation study and application of stratum-specific likelihood ratios in the Chinese version of SPAN.Compr Psychiatry,44,78-81.
7. Cheung, YT,Lim, SR,Shwe, M(2013).Psychometric properties and measurement equivalence of the English and Chinese versions of the functional assessment of cancer therapy-cognitive in Asian patients with breast cancer.Value Health,16,1001-1013.
8. Cheville, AL,Novotny, PJ,Sloan, JA(2011).The value of a symptom cluster of fatigue, dyspnea, and cough in predicting clinical outcomes in lung cancer survivors.J Pain Symptom Manage,42,213-221.
9. Cohn, E,Lurie, I,Yang, YX(2018).Posttraumatic stress disorder and cancer risk: A nested case-control study.J Trauma Stress,31,919-926.
10. Dalton, AF,Bunton, AJ,Cykert, S(2014).Patient characteristics associated with favorable perceptions of patient-provider communication in early-stage lung cancer treatment.J Health Commun,19,532-544.
11. Di Maio, M,Signoriello, S,Morabito, A(2012).Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials.Lung Cancer,76,457-464.
12. Dougall, AL,Swanson, J,Kyutoku, Y(2017).Posttraumatic symptoms, quality of life, and survival among lung cancer patients.J Appl Biobehav Res,22,e12065.
13. Feng, Y,Parkin, D,Devlin, NJ(2014).Assessing the performance of the EQ-VAS in the NHS PROMs programme.Qual Life Res,23,977-989.
14. Flory, JD,Yehuda, R(2015).Comorbidity between post-traumatic stress disorder and major depressive disorder: alternative explanations and treatment considerations.Dialogues Clin Neurosci,17,141-150.
15. Greer, JA,Pirl, WF,Park, ER(2008).Behavioral and psychological predictors of chemotherapy adherence in patients with advanced non-small cell lung cancer.J Psychosom Res,65,549-552.
16. Herndon, JE, 2nd,Kornblith, AB,Holland, JC(2008).Patient education level as a predictor of survival in lung cancer clinical trials.J Clin Oncol,26,4116-4123.
17. Howington, JA,Blum, MG,Chang, AC(2013).Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines.Chest,143,S278-S313.
18. Iachina, M,Brønserud, MM,Jakobsen, E(2017).History of depression in lung cancer patients: impact of delay.Clin Oncol,29,585-592.
19. Jacobsen, PB,Widows, MR,Hann, DM(1998).Posttraumatic stress disorder symptoms after bone marrow transplantation for breast cancer.Psychosom Med,60,366-371.
20. Jeantieu, M,Gaillat, F,Antonini, F(2014).Postoperative pain and subsequent PTSD-related symptoms in patients undergoing lung resection for suspected cancer.J Thorac Oncol,9,362-369.
21. Jia, Y,Li, F,Liu, YF(2017).Depression and cancer risk: a systematic review and meta-analysis.Public Health,149,138-148.
22. Kangas, M,Henry, JL,Bryant, RA(2002).Posttraumatic stress disorder following cancer. a conceptual and empirical review.Clin Psychol Rev,22,499-524.
23. Kleiman, V,Clarke, H,Katz, J(2011).Sensitivity to pain traumatization: A higher-order factor underlying pain-related anxiety, pain catastrophizing and anxiety sensitivity among patients scheduled for major surgery.Pain Res Manag,16,169-177.
24. Koopman, C,Classen, C,Spiegel, D(1994).Predictors of posttraumatic stress symptoms among survivors of the Oakland/Berkeley, Calif., firestorm.Am J Psychiatry,151,888-894.
25. Kroenke, K,Spitzer, RL,Williams, JB(2001).The PHQ-9: Validity of a brief depression severity measure.J Gen Intern Med,16,606-613.
26. Lee, MJ,Huang, CW,Lee, CP(2021).Investigation of anxiety and depressive disorders and psychiatric medication use before and after cancer diagnosis.Psychooncology,30,919-927.
27. Lin, J,McGlynn, KA,Carter, CA(2016).The impact of preexisting mental health disorders on the diagnosis, treatment, and survival among lung cancer patients in the U.S. military health system.Cancer Epidemiol Biomarkers Prev,25,1564-1571.
28. Lin, JJ,Lake, J,Wall, MM(2014).Association of patient-provider communication domains with lung cancer treatment.J Thorac Oncol,9,1249-1254.
29. McFarlane, AC,Papay, P(1992).Multiple diagnoses in posttraumatic stress disorder in the victims of a natural disaster.J Nerv Ment Dis,180,498-504.
30. Nasim, F,Sabath, BF,Eapen, GA(2019).Lung cancer.Med Clin North Am,103,463-473.
31. Ni, J,Feng, J,Denehy, L(2018).Symptoms of posttraumatic stress disorder and associated risk factors in patients with lung cancer: a longitudinal observational study.Integr Cancer Ther,17,1195-1203.
32. O’brien, RM(2007).A caution regarding rules of thumb for variance inflation factors.Qual Q,41,673-690.
33. Pereira, MA,Araújo, A,Simões, M(2021).Influence of psychological factors in breast and lung cancer risk – a systematic review.Front Psychol,12,769394.
34. Redd, WH,DuHamel, KN,Vickberg, SM(2001).Long-term adjustment in cancer survivors: Integration of classical-conditioning and cognitive-processing models.Psychosocial Interventions for Cancer,Washington DC:
35. Tchekmedyian, NS,Kallich, J,McDermott, A(2003).The relationship between psychologic distress and cancer-related fatigue.Cancer,98,198-203.
36. Thuné-Boyle, IC,Myers, LB,Newman, SP(2006).The role of illness beliefs, treatment beliefs, and perceived severity of symptoms in explaining distress in cancer patients during chemotherapy treatment.Behav Med,32,19-29.
37. Tishelman, C,Degner, LF,Rudman, A(2005).Symptoms in patients with lung carcinoma: Distinguishing distress from intensity.Cancer,104,2013-2021.
38. Tishelman, C,Petersson, LM,Degner, LF(2007).Symptom prevalence, intensity, and distress in patients with inoperable lung cancer in relation to time of death.J Clin Oncol,25,5381-5389.
39. van Hout, B,Janssen, MF,Feng, YS(2012).Interim scoring for the EQ-5D-5L: Mapping the EQ-5D-5L to EQ-5D-3L value sets.Value Health,15,708-715.
40. Walker, J,Hansen, CH,Martin, P(2014).Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: A cross-sectional analysis of routinely collected clinical data.Lancet Psychiatry,1,343-350.
41. Wang, YH,Li, JQ,Shi, JF(2020).Depression and anxiety in relation to cancer incidence and mortality: a systematic review and meta-analysis of cohort studies.Mol Psychiatry,25,1487-1499.
42. World Health Organization(2021).World Health Organization: Cancer. Geneva, Swilzerland: World Health Organization. 2021..
43. Yeager, DE,Magruder, KM,Knapp, RG(2007).Performance characteristics of the posttraumatic stress disorder checklist and SPAN in veterans affairs primary care settings.Gen Hosp Psychiatry,29,294-301.